Addyi
My Prescription
Payment
Select pharmacy
$298.80
Print or send this coupon to your phone
AlbertsonsPowered byAbout Addyi
Drug Details
Flibanserin, marketed as Addyi, is a medication specifically designed for women who have not yet entered menopause and are experiencing hypoactive sexual desire disorder (HSDD), which is characterized by a low sexual drive. This treatment is not suitable for postmenopausal women or men and is ineffective for addressing low sexual desire resulting from medical, mental, relationship issues, or other drug effects. The primary benefit of flibanserin is its ability to enhance sexual desire, increase the number of satisfying sexual experiences, and alleviate stress associated with low sexual desire. The medication is taken as a tablet once daily at bedtime. Flibanserin functions as a serotonin receptor agonist and antagonist, though its exact mechanism of action is not fully understood. It is believed to influence serotonin receptors in the brain, which could help improve sex drive, as serotonin is a key chemical that regulates mood and sexual desire. Patients should be aware of potential side effects, including dizziness, sleepiness, and nausea. Additionally, there are important alcohol restrictions due to the risk of low blood pressure and fainting during treatment. Always consult a healthcare professional before starting any new medication to ensure it is safe and effective for your individual needs.
Price history for Addyi
30 Tablets, 100MG
Average retail price for Addyi
Average SaveHealth price for Addyi
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Addyi dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 100MG | 30 Tablets | $2,048.79 | $68.29 |
Addyi FAQs
Addyi, also known as flibanserin, is a medication used to treat premenopausal women with hypoactive sexual desire disorder (HSDD). It works by affecting certain chemicals in the brain that are related to mood and desire, aiming to increase sexual desire and reduce distress associated with low sexual desire. It is important to note that Addyi is not for use in postmenopausal women or men, and it should not be taken with alcohol due to the risk of severe low blood pressure and fainting.
Addyi should not be taken by individuals who consume alcohol, as it can lead to severe hypotension and syncope. It is also contraindicated in those with liver impairment and those taking moderate or strong CYP3A4 inhibitors. Additionally, it is not recommended for individuals who are pregnant, breastfeeding, or have a history of hypersensitivity to the drug.
Addyi was originally developed as an antidepressant. However, during clinical trials, it was found to have a significant effect on increasing sexual desire in women, which led to its approval for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women.
Addyi (flibanserin) has several contraindications. It should not be used in individuals who consume alcohol, as this combination can lead to severe hypotension and syncope. It is also contraindicated in patients with hepatic impairment and those taking moderate or strong CYP3A4 inhibitors, as these can increase the risk of adverse reactions. Additionally, it should not be used in individuals with a known hypersensitivity to flibanserin or any of its components.
The success rate of Addyi (flibanserin) can vary among individuals. Clinical trials have shown that approximately 10% more women taking Addyi reported a meaningful improvement in sexual desire compared to those taking a placebo. It is important to note that results can differ based on individual factors, and patients should discuss expectations and potential outcomes with their healthcare provider.